Application no. and date | 01922935.0 (espacenet) (Federated) (European Patent Register), 20010330 | Patent/reg. no. and date | DK/EP 1274414, 20100505 | Publication date | 20030115 | Priority no. and date | US 193181 P, 20000330 | EP pub. no. and date |
EP 1274414 20030115 | Effective date | | Applicant/owner | Evoke Pharma, Inc., 12636 High Bluff Drive, Suite 400
San Diego CA 92130, US | Applicant ref. no. | 10069-1 | Inventor | LEHMAN, Laura, S., 25 Erstwild Court
Palo Alto, CA 94303, US, TIERNEY, David, 12 Straus Drive
Shrewsbury, NJ 07702, US, RETZIOS, Anastassios, D., 26118 Research Road
Hayward, CA 94545, US, PETRONE, Michael, 173 William Feather Drive
Voorhees, NJ 08043, US, YOUNG, David, 4131 Pemberton Court
Elliott City, MD 20134, US, TRAPNELL, Carol, B., 4034 Larkspring Row
Ellicott City, MD 20142, US, OLIVER, Ruth, 88 Westborough Road
Maidenhead SL6 4AS, GB | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 31/166 (2006.01) , A61K 9/08 (2006.01) , A61P 1/14 (2006.01) | Title | Nasal administration af Metocloropramid til behandling af Gastroparese | Int. application no. | US2001010356 | Int. publication no. | WO2001074350 | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|